Inhibiting IL‐1 signaling pathways to inhibit catabolic processes in disc degeneration

Journal of Orthopaedic Research - Tập 35 Số 1 - Trang 74-85 - 2017
J. Daniels1, Abbie A. L. Binch1, Christine L. Le Maitre1
1Biomolecular Sciences Research Centre, Sheffield Hallam University, S1 1WB, Howard Street, Sheffield, South Yorkshire, Sheffield, United Kingdom

Tóm tắt

ABSTRACTIntervertebral disc degeneration is characterized by an imbalance between catabolic and anabolic signaling, with an increase in catabolic cytokines particularly IL‐1β, a key regulator of IVD degeneration. This study aimed to investigate intracellular signaling pathways activated by IL‐1β, and GDF‐5 in the degenerate IVD to identify potential new therapeutic targets. Human NP cells were cultured in alginate beads to regain in vivo phenotype prior to stimulation with IL‐1β or GDF‐5 for 30 min, a proteasome profiler array was initially utilized to screen activation status of 46 signaling proteins. Immunoflourescence was used to investigate activation of the NFκB pathway. Cell‐based ELISAs were then deployed to confirm results for ERK1/2, p38 MAPK, c‐jun, and IκB signaling. IHC was utilized to investigate native activation status within human IVD tissue between grades of degeneration. Finally, cells were stimulated with IL‐1β in the absence or presence of p38 MAPK, c‐jun, JNK, and NFκB inhibitors to investigate effects on MMP3, MMP13, IL‐1β, IL‐6, and IL‐8 mRNA expression. This study demonstrated three key signaling pathways which were differentially activated by IL‐1β but not GDF‐5; namely p38 MAPK, c‐jun, and NFκB. While ERK 1/2 was activated by both GDF‐5 and IL‐1. Immunohistochemistry demonstrated p38 MAPK, c‐jun, and NFκB were activated during human IVD degeneration and inhibition of these pathways reduced or abrogated the catabolic effects of IL‐1β, with inhibition of NFκB signaling demonstrating most widespread inhibition of IL‐1β catabolic effects. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:74–85, 2017.

Từ khóa


Tài liệu tham khảo

10.22203/eCM.v008a06

10.1097/01.brs.0000146101.53784.b1

Le Maitre CL, 2015, Degeneration of the intervertebral disc with new approaches for treating low back pain, J Neurosurg Sci, 59, 47

10.1042/BST0350652

10.1038/nrrheum.2013.160

10.1186/ar1732

10.1093/rheumatology/ken056

10.1186/s13075-014-0416-1

10.1016/j.joca.2015.02.017

10.1186/ar4408

10.1136/annrheumdis-2012-202266

10.1196/annals.1397.069

10.1007/s00586-005-0988-1

10.1007/s00586-009-1139-x

10.1097/01.ede.0000135179.04563.35

10.1007/s00586-011-1915-2

10.1097/01.brs.0000248428.22823.86

10.1016/j.spinee.2009.10.006

10.1186/ar2808

10.1186/ar4505

10.1002/path.1862

10.1097/BRS.0b013e31815b757a

10.1002/jor.20604

10.1186/s13018-015-0296-3

Ma T, 2015, The effect of curcumin on NF‐kappaB expression in rat with lumbar intervertebral disc degeneration, Eur Rev Med Pharmacol Sci, 19, 1305

10.1097/BRS.0000000000000733

10.22203/eCM.v023a08

10.1016/j.ajpath.2014.06.006

10.1074/jbc.M304058200

10.1016/j.matbio.2006.07.002

10.1074/jbc.273.50.33508

10.1186/1476-9255-9-29

10.1016/j.ajpath.2013.02.037

10.1016/j.cellsig.2008.10.006

10.1074/jbc.M200218200

10.1016/j.neulet.2014.03.045

10.1002/art.39036

10.1128/MCB.22.4.1203-1217.2002

10.1002/art.24248

10.1002/jor.22699

10.1186/ar2198

10.1007/s00586-001-0383-5

10.1097/BRS.0b013e31815b9850

10.1196/annals.1397.090

10.1007/s12013-014-0417-3

Yu ZG, 2009, Interleukin‐1 inhibits Sox9 and collagen type II expression via nuclear factor‐kappaB in the cultured human intervertebral disc cells, Chin Med J, 122, 2483

10.4049/jimmunol.163.6.3474

10.1097/BRS.0b013e31824ee8f7

Thông tin
Thông tin xuất bản

Journal of Orthopaedic Research

Tập 35 Số 1

74-85

Thông tin tác giả